Blocking potassium channels (Kv1.3): A new treatment option for alopecia areata?

Journal of Investigative Dermatology

Volumn 133, Issue 8, 2013, Pages 2088-2091

  Gilhar, Amos ^a   Keren, Aviad ^a   Shemer, Avner ^a   Ullmann, Yehuda ^a   Paus, Ralf ^b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.3;

ALOPECIA AREATA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HUMAN; IN VITRO STUDY; INFLAMMATORY INFILTRATE; LETTER; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCID MOUSE; SKIN BIOPSY; T LYMPHOCYTE ACTIVATION;

EID: 84880325408     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.141     Document Type: Letter

References (14)

1. Beeton C, Smith BJ, Sabo JK et al. (2008) The D-diastereomer of ShK toxin selectively blocks voltage-gated K\+ channels and inhibits T lymphocyte proliferation. J Biol Chem 283:988-97
2. Beeton C, Wulff H, Barbaria J et al. (2001) Selective blockade of T lymphocyte K(\+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:13942-7 (Pubitemid 33116003)
3. Beeton C, Wulff H, Standifer NE et al. (2006) Kv1.3 channels are a therapeutic target for T cellmediated autoimmune diseases. Proc Natl Acad Sci USA 103:17414-9 (Pubitemid 44788983)
4. Feske S, Skolnik EY, Prakriya M (2012) Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol 12:532-47
5. Gilhar A, Bergman R, Assay B et al. (2011) The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. J Invest Dermatol 131:118-24
6. Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366:1515-25
7. Gilhar A, Keren A, Shemer A et al. (2013) Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol 133: 844-7
8. Ito T, Ito N, Saatoff M et al. (2008) Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128:1196-206 (Pubitemid 351543218)
9. Petukhova L, Duvic M, Hordinsky M et al. (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113-7
10. Schmitz A, Sankaranarayanan A, Azam P et al. (2005) Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol 68: 1254-70 (Pubitemid 41539982)
11. Szabò I, Zoratti M, Gulbins E (2010) Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett 584: 2049-56
12. Wulff H, Beeton C, Chandy KG (2003a) Potassium channels as therapeutic targets for autoimmune disorders. Curr Opin Drug Discov Dev 6:640-7 (Pubitemid 37287933)
13. Wulff H, Calabresi PA, Allie R et al. (2003b) The voltage-gated Kv1.3 K(\+) channel in effector memory T cells as new target for MS. J Clin Invest 111:1703-13 (Pubitemid 38057751)
14. Wulff H, Castle NA, Pardo LA (2009) Voltagegated potassium channels as therapeutic targets. Nat Rev Drug Discovery 8:982-1001